In the world of business and industry, for many mergers and acquisitions are the daily bread. Anytime a company is combined with another company, there are numerous ramifications that immediately follow.
This is even more true with innovation-driven industries such as IT or life sciences. Proper valuation of the companies in question is vital in order to ensure a fair outcome. This is easier said than done sometimes. The requirements of high-growth and innovation sectors of the economy require an in-depth understanding of often-misunderstood aspects of valuations such as determining the value of intangible assets or pre-revenue companies funded exclusively by investors prior to going public.
We have worked in mergers and acquisitions for years with some of the largest firms in banking and private equity. We know the territory. We also realize that, while we do follow a formal process, there is no single formula, guideline or calculation that results in a “fair” market value. Every client has specific needs and every project requires a standard of value appropriate to the client’s goals. A credible valuation is based on thorough quantitative analysis of all relevant facts, combined with many qualitative judgments to arrive at the proper determination of value.
We know that an educated and experienced staff is only one part of developing a top-notch analysis team. It requires a commitment to quality and the ability to communicate effectively with all relevant parties, including boards of directors, company management and staff, regulatory authorities (such as the SBA, SEC and IRS), equity investors, lenders and bondholders, and corporate buyers.
Areas of Focus:
-
Partial or Total Corporate Sale
-
Buy or Sell Side Liquidation of Minority Interests
-
Management Buyouts/ Leveraged Buyouts
-
Strategic Mergers
-
Divestitures or Spin-Offs
-
Recapitalizations and Restructures
-
Cross-Border Transactions
-
Owner Exits
-
Succession Planning
-
Purchase Price Allocation
-
M&A Advisory
-
Fairness and Solvency Opinions